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ABSTRACT 
A novel, simple, accurate and precise UV-visible spectroscopic method for determination albuterol in buffer-ethanol (1:1) system has been 
developed and validated. The linearity is obeyed over a concentration range of 10-100 μg/ml with correlation coefficient of 0.9989 for drug. 
The proposed method was validated by determining accuracy, precision and stability parameters. The method was found to be robust. The 
method was used successfully for the determination of albuterol in aerosol dosage form.  
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INTRODUCTION 
Albuterol is a beta-adrenergic agonist used as an anti-
asthmatic drug 1. Albuterol is used for the treatment and 
prevention of bronchospasm (acute or severe) in patients 
with reversible obstructive airway disease 2-4. It is also 
indicated for the prevention of exercise-induced 
bronchospasm. Albuterol acts on beta-2-receptors to relax 
the bronchial smooth muscle 5-7. It also inhibits the release of 
immediate hypersensitivity mediators from cells, especially 
mast cells. Although albuterol affects beta-1-receptors, this is 
minimal and has little effect on the heart rate 8-10. Albuterol 
comes in a variety of dosing forms and strengths. An aerosol 
metered-dose inhaler gives 90 mcg (base)/actuation, which 
is equivalent to 108 mcg of albuterol sulfate. The powder 
metered-dose inhaler form gives the same values as the 
aerosol metered-dose inhaler. Albuterol also is offered in 2 
mg and 4 mg tablets 11-13. There are several methods for 
estimation of albuterol. The present study deals with 
estimation of albuterol in ethanol-buffer system.  It is official 
in Indian pharmacopoeia 14. It is estimated by acid-base 
titration method as per Indian pharmacopoeia and British 
pharmacopoeia [14]. The literature review reveals that HPLC 
15 and UV spectrophotometric methods 16 have been 
reported for estimation of albuterol in pharmaceutical 
dosage forms. But for routine analysis, no simple and 
accurate method is available for determination of albuterol 
in tablet dosage form. The aim of present work is to find out 
a simple, sensitive, specific, spectrophotometric method and 
its validation for estimation of albuterol from pharmaceutical 
formulation. The present study deals with estimation of 
albuterol in ethanol-buffer system.   
MATERIAL AND METHOD 
Instruments 
UV-Visible double beam spectrophotometer (UV-1700, 
SHIMADZU Co, Japan) with 1cm matched quartz cells, 
Micropipette of Variable volume 10-1000 μL (Gene Pete Co.) 
and Digital balance (Citizen Co.) were used. 
Chemicals 
Albuterol was purchased from Sigma Eldrich, Germany. The 
formulation of albuterol Asthalin, Cipla) was purchased from 
local market. All other used in the present study were of 
analytical grade. Triple distilled water was used in the 
present study. All chemicals and reagents used were of 
analytical grade.  
Preparation of Standard Stock Solution 
The standard stock solution was prepared by dissolving 
albuterol in 0.1N HCl to make final concentration of 
200μg/ml. Different aliquots were taken from stock solution 
and diluted with 0.1N HCl separately to prepare series of 
concentrations from 10-120 μg/ml. The λmax was found by 
UV spectrum of albuterol in 0.1NHCl: ethanol (1:1), in the 
range of 200-400 nm and it was found to be 276 nm. 
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Absorbance was measured at 276 nm against 0.1N HCl as 
blank. The calibration curve was prepared by plotting 
absorbance versus concentration (μg/ml) of albuterol. 
Determination of Albuterol in dosage form 
The proposed method was applied in order to determine the 
albuterol in formulation. The marketed tablet formulation of 
albuterol was used for this. The powder equivalent to 100 
mg of albuterol was transferred in 100 ml volumetric flask 
and dissolved in 0.1NHCl by shaking. The volume was made 
up to mark to get final concentration of 1mg/ml. Frequent 
shaking given and volume was made up to 100ml mark with 
0.1N HCL. The solution was then filtered through Whattman 
filter paper #01.This filtrate was diluted suitably with 
0.1NHCl: ethanol (1:1) to get the solution of 100μg/ml 
concentration. The working solution of drug (100μg/ml) was 
prepared from standard stock solution in 0.1NHCl: ethanol 
(1:1). The absorbance of this solution was measured and 
amount of albuterol was calculated from the calibration 
curve. The readings were taken in triplicate. 
Method Validation 
According to the  ICH guidelines, accuracy, precision, LOD, 
LOQ and linearity of the calibration curve were 
determined(Guideline, 2005). For linear response 
measurement, the least squares method was applied. The 
statistical analysis was calculated by ANOVA. Amounts of 60 
and 80μg/ml of albuterol standard solution were added into 
pre analysed 60 and 80μg/ml samples and absorbance were 
measured and the recovery was calculated. 
RESULTS AND DISCUSSION 
Under experimental conditions described, linearity, assay of 
tablet, accuracy studies and precision were performed. In 
this study, linearity was observed in the concentration range 
of 2-10μg/ml and 2-20 μg/ml for albuterol and correlation 
coefficient was found to be > 0.998. The results of 
commercial formulation are presented in Table 1and figure 
1. Results of accuracy studies are presented in Table 2.  
Table 1: results obtained after analysis of albuterol 
Parameters Results 
Absorption maxima(nm) 276 
Linearity Range (μg/ml) 10-100 
Standard Regression Equation Y = 0.002x +0.0823 
Correlation Coefficient (r2 ) 0.9989 
Accuracy (% recovery ±SD) 98.57±0.239 
Precision (%) 1.628±0.326(Intraday)  
1.279±0.215(Interday) 
LOD (μg/ml) 4.239 
LOQ (μg/ml) 12.708 
%Drug found in formulation 99.78 
 
 
Figure 1: calibration curve of albuterol 
 
Table 2: results of precision and recovery 
S. 
No. 
Amount of 
drug from 
formulation 
% 
Addition 
 
Amount 
added 
(μg/ml) 
Amount 
recovered 
(μg/ml) 
% 
Recovery 
 
Precision 
(Intra 
day)* 
Precision 
(Inter 
day)* 
1. Albuterol 60 100 60 59.19 1.55 1.26 
 
Standard addition method was used to assess the accuracy. 
For evaluating precision, the selected concentration (60 
μg/ml) were prepared in 0.1N HCL and analyzed to 
determine the intraday and inter day variability. The intra-
day and inter day precision were determined. The precision 
and accuracy of the analysis are given in Tables 2, indicates 
high precision and accuracy. 
 
Table 3: determination of albuterol in formulation 
Formulation Claimed amount Amount found Percent content 
Albuterol 100 µg 98.235±0.358 98.23 
 
Content of albuterol found in the marketed method from the 
proposed method is shown in Table 3. The % purity was 
98.23%. 
CONCLUSION 
The two methods was developed and validated as per ICH 
guidelines. The standard deviation and % RSD calculated for 
the proposed methods are within limits, indicating high 
degree of precision of the methods. The results of the 
recovery studies performed indicate the methods to be 
accurate. Hence, it can be concluded that the developed 
spectrophotometric method is accurate, precise and can be 
employed successfully for the estimation of albuterol and 
ambroxol in bulk and formulation. 
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